Literature DB >> 11724151

Nationwide campaign for vaccination of adults against rubella and measles--Costa Rica, 2001.

.   

Abstract

In 1999 in Costa Rica, a large rubella outbreak occurred among persons aged 15-45 years. In response, the Ministry of Health adopted the goal of eliminating rubella and congenital rubella syndrome (CRS). In 2001, a nationwide vaccination campaign reached approximately 1.6 million (>95%) persons aged 15-39 years. This report highlights successful aspects of the campaign, including effective planning, cooperation among government ministries, social mobilization, the use of house-to-house vaccination teams, daily coverage reports from local staff, vaccine safety monitoring, and strategies for ensuring a sufficient national blood supply. This campaign will strengthen measles eradication and lead to rubella and CRS elimination in Costa Rica.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724151

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  3 in total

1.  Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013.

Authors:  Lakshmi Sukumaran; Michael M McNeil; Pedro L Moro; Paige W Lewis; Scott K Winiecki; Tom T Shimabukuro
Journal:  Clin Infect Dis       Date:  2015-01-30       Impact factor: 9.079

Review 2.  Highly affordable vaccines are critical for our continued efforts to reduce global childhood mortality.

Authors:  Stefan H E Kaufmann
Journal:  Hum Vaccin Immunother       Date:  2019-05-17       Impact factor: 3.452

3.  Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.

Authors:  Zhifang Wang; Rui Yan; Hanqing He; Qian Li; Guohua Chen; Shengxu Yang; Enfu Chen
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.